Tag: dianon systems

December 28, 2015 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

To advance the practice of precision medicine through better use of genetic testing, a new limited liability corporation (LLC) was formed. Participating in the LLC are North Shore-LIJ Health System, the nation’s largest urban health system, OPKO Health, Inc., a pharmaceutical company, and GeneDx, a division of Bio-Reference Laboratories (both lab businesses are owned by OPKO).

View Article

December 7, 2015 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

Last week, a joint laboratory accreditation agreement was announced by AABB and the American Association for Laboratory Accreditation (A2LA). The two associations will now collaborate to allow labs to obtain three assessments under one effort, including AABB accreditation, ISO 15189 accreditation, and CLIA requirements. In their statement about the benefits of the new arrangement, the

View Article

October 13, 2014 “Intelligence: Late-Breaking Lab News”

Quality management systems (QMS) have made inroads in some of the organizations that accredit clinical laboratories in the United States to the requirements of CLIA. Last month, COLA of Columbia, Maryland, acknowledged that it had recertified to the standards of ISO 9001: 2008. The recertification was obtained through the British Standards Institute. COLA earned its

View Article

December 2, 2013 “Intelligence: Late-Breaking Lab News”

Despite the continuing cutbacks in reimbursement for lab testing, some professional investors still see opportunity in this market sector. On November 13, Genova Diagnostics, Inc., of Asheville, North Carolina, was acquired by Levine Leichtman Capital Partners and “members of management.” The sellers were Nautic Partners and Ferrer Freeman & Company, LLC. Genova’s CEO is Ted

View Article

Rosetta Genetics, Aureon Biosciences, Plus Diagnostics, Atherotech, Sequenom

ROSETTA GENOMICS TO LAY OFF 35 EMPLOYEES
TO CUT EXPENSES AND SHIFT MORE FUNDING toward sales of its proprietary molecular tests, Rosetta Genomics says it will eliminate 35 jobs. The company, based in Israel, operates a clinical laboratory in Philadelphia, Pennsylvania.

The Philadelphia laboratory employs eight people, but Rosetta did not disclose whether staff layoffs would happen

View Article